R. Jenkins

Apixaban following discharge in hospitalised adults with COVID-19: Preliminary results from a multicentre, open-label, randomised controlled platform clinical trial.

M. Landray, J. Baillie, T. Jaki, 2022, medRxiv.

Clinical characteristics with inflammation profiling of Long-COVID and association with one-year recovery following hospitalisation in the UK: a prospective observational study

L. Wain, W. Man, C. Brightling, 2021, medRxiv.

Prasugrel Plus Aspirin Beyond 12 Months Is Associated With Improved Outcomes After Taxus Liberté Paclitaxel-Eluting Coronary Stent Placement

W. Weaver, L. Mauri, D. Kereiakes, 2015, Circulation.

Response to letters regarding article, "prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placement".

W. Weaver, L. Mauri, D. Kereiakes, 2015, Circulation.

Three month FVC change: a potential trial endpoint for IPF based on individual participant data meta-analysis

L. Fabbri, Simon R. Johnson, K. Robinson, 2021, medRxiv.

Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study

Paul J. Harrison, Jennifer M. Brown, Gary F. Simons, 2022, The Lancet. Respiratory medicine.